A new study led by investigators from Mass General Brigham trialed stereotactic (targeted) brain-directed radiation in 100 ...

New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for ...

An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

It all started with frequent stomach aches about four years ago,” Mrs Agnes Acholi recalled. “From there, each episode of abdominal pain became progressively worse, and I sought medical treatment.”The ...

Paclitaxel (PTX) remains a cornerstone in the treatment of locally advanced and metastatic lung cancer. To improve its therapeutic indices against lung cancer, novel redox-sensitive pullulan/PTX-based ...

The results show that camptothecin nanocrystals were capable of eliciting greater antimetastatic efficacy and achieve a longer survival time in the murine model compared with camptothecin salt ...

A South Korean research team has accomplished what was once thought of as science fiction: reprogramming malignant cancer cells into healthy, functional tissue without chemotherapy or radiation in a ...

1. As of April, the production of specialized immune-cell therapies for metastatic cancer patients was delayed due to NIH staff cuts that fired several skilled lab technicians who create the drugs.

Until now, cancer studies have focused on first-line therapy and lacked the flexibility to modify treatments as tumors grow. City of Hope will design its clinical trial to adjust treatment as ...

New lipid nanoparticles like U155 dramatically improve lung gene editing, unlocking safer and more effective genetic therapies.

Both non-small lung cancer and small cell lung cancer is a disease that now has various therapeutic options available, according to experts.